These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36682472)

  • 1. Pericardial Effusion as a Purported Manifestation of Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation.
    Matin A; Smith BH; Mangaonkar A; Duffy DJ; Wolf R; Alkhateeb H; Shah MV; Hogan WJ; Litzow MR
    Transplant Cell Ther; 2023 May; 29(5):324.e1-324.e6. PubMed ID: 36682472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation-association with chronic GVHD in late-onset adult patients.
    Liu YC; Gau JP; Hong YC; Yu YB; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    Ann Hematol; 2012 Dec; 91(12):1953-8. PubMed ID: 22869091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presalvage International Staging System Stage and Other Important Outcome Associations in CD34
    Bryant AR; Hilden P; Giralt S; Chung DJ; Maloy M; Landau H; Landgren O; Scordo M; Shah G; Smith EL; O'Reilly RJ; Perales MA; Koehne G
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):58-65. PubMed ID: 31493537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.
    Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Badawy SM; Bhatt N; Bhatt VR; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Hashmi S; Hematti P; Hossain NM; Inamoto Y; Lekakis LJ; Sharma A; Solomon S; Lee SJ; Couriel DR
    Transplant Cell Ther; 2024 Jan; 30(1):97.e1-97.e14. PubMed ID: 37844687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Pericarditis following Allogeneic Hematopoietic Cell Transplantation.
    Freyer CW; Fradley M; Madnick D; Carver JR; Frey NV; Gill SI; Ky B; Luger SM; Martin ME; McCurdy SR; O'Quinn R; Perl AE; Stadtmauer EA; Loren AW
    Transplant Cell Ther; 2021 Nov; 27(11):934.e1-934.e6. PubMed ID: 34339867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation.
    Chirumbolo G; Dicataldo M; Barone M; Storci G; De Matteis S; Laprovitera N; Sinigaglia B; Barbato F; Maffini E; Cavo M; Bonifazi F; Arpinati M
    Transplant Cell Ther; 2023 May; 29(5):302.e1-302.e8. PubMed ID: 36796518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
    Arora M; Cutler CS; Jagasia MH; Pidala J; Chai X; Martin PJ; Flowers ME; Inamoto Y; Chen GL; Wood WA; Khera N; Palmer J; Duong H; Arai S; Mayer S; Pusic I; Lee SJ
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):449-55. PubMed ID: 26541363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic Transplantation.
    Magenau J; Braun T; Gatza E; Churay T; Mazzoli A; Chappell G; Brisson J; Runaas L; Anand S; Ghosh M; Riwes M; Pawarode A; Yanik G; Reddy P; Choi SW
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1682-1688. PubMed ID: 30710686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients.
    Cheng G; Smith MA; Phelan R; Brazauskas R; Strom J; Ahn KW; Hamilton B; Peterson A; Savani B; Schoemans H; Schoettler M; Sorror M; Higham C; Kharbanda S; Dvorak CC; Zinter MS
    Transplant Cell Ther; 2024 Oct; 30(10):1017.e1-1017.e12. PubMed ID: 39089527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for and the Prognostic Impact of Pericardial Effusion after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kubo H; Imataki O; Fukumoto T; Oku M; Ishida T; Kubo YH; Kida JI; Uemura M; Fujita H; Ohno H; Ide M; Ohnishi H; Kadowaki N
    Transplant Cell Ther; 2021 Nov; 27(11):949.e1-949.e8. PubMed ID: 34333179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation.
    Saberian C; Abdel-Wahab N; Abudayyeh A; Rafei H; Joseph J; Rondon G; Whited L; Gruschkus S; Fa'ak F; Daher M; Knape C; Safa H; Shoukier M; Suarez-Almazor ME; Marcotulli M; Ludford K; Gulbis AM; Konopleva M; Ohanian M; Ravandi F; Garcia-Manero G; Oran B; Popat UR; Mehta R; Alousi AM; Daver N; Champlin R; Diab A; Al-Atrash G
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation.
    Patel SS; Ahn KW; Khanal M; Bupp C; Allbee-Johnson M; Majhail NS; Hamilton BK; Rotz SJ; Hashem H; Beitinjaneh A; Lazarus HM; Krem MM; Prestidge T; Bhatt NS; Sharma A; Gadalla SM; Murthy HS; Broglie L; Nishihori T; Freytes CO; Hildebrandt GC; Gergis U; Seo S; Wirk B; Pasquini MC; Savani BN; Sorror ML; Stadtmauer EA; Chhabra S
    Transplant Cell Ther; 2022 Jun; 28(6):310-320. PubMed ID: 35314376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients.
    Rhodes M; Lautz T; Kavanaugh-Mchugh A; Manes B; Calder C; Koyama T; Liske M; Parra D; Frangoul H
    Bone Marrow Transplant; 2005 Jul; 36(2):139-44. PubMed ID: 15908968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large pericardial effusion as a complication in adults undergoing SCT.
    Norkin M; Ratanatharathorn V; Ayash L; Abidi MH; Al-Kadhimi Z; Lum LG; Uberti JP
    Bone Marrow Transplant; 2011 Oct; 46(10):1353-6. PubMed ID: 21113188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Tzeng CH
    Br J Haematol; 2015 Jun; 169(5):737-45. PubMed ID: 25818840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Beta-Blocker Use at the Time of Hematopoietic Cell Transplantation on the Development of Acute and Chronic Graft-Versus-Host Disease.
    Patel A; Murthy GSG; Hamadani M; Szabo A; Knight JM
    Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):209-216. PubMed ID: 34780786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
    Hosoba S; Waller EK; Shenvi N; Graiser M; Easley KA; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Josephson CD; Koff JL; Khoury HJ; Langston AA; Zimring JC; Roback JD; Giver CR
    Biol Blood Marrow Transplant; 2018 May; 24(5):973-982. PubMed ID: 29307717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-Sensitive and Treatment-Dependent Chronic Graft-versus-Host Disease Yield Superior Failure-Free and Overall Survival Compared to Treatment-Resistant Chronic Graft-versus-Host Disease.
    El Jurdi N; Herzog S; Shanley R; Holtan SG; MacMillan ML; Weisdorf DJ
    Transplant Cell Ther; 2024 Jun; 30(6):616-625. PubMed ID: 38479549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
    Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Auletta JJ; Badawy SM; Bhatt N; Bhatt VR; Cahn JY; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Gale RP; Hashem H; Hashmi S; Hematti P; Hong S; Hossain NM; Inamoto Y; Lekakis LJ; Modi D; Patel S; Sharma A; Solomon S; Couriel DR
    Transplant Cell Ther; 2022 Oct; 28(10):712.e1-712.e8. PubMed ID: 35863740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.